CHPA also requested a meeting with FDA’s leadership to ensure the proposed organization structure would not dilute the prioritization of dietary supplements.
Generic Banzel is used for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children aged 4 years old and older and adults.